The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Open accessAbstract
Psoriasis is a common chronic autoimmune skin disease of unknown cause that involves dysregulated interplay between immune cells and keratinocytes. IL-22 is a cytokine produced by the TH1, TH17, and TH22 subsets that are functionally implicated in the psoriatic pathology. We assessed the role of IL-22 in a mouse model where psoriasiform skin inflammation is triggered by topical application of the TLR7/8 agonist imiquimod. At the macroscopic level, scaly skin lesions induced by daily applications of imiquimod in wild-type mice were almost totally absent in IL-22–deficient mice or in mice treated with a blocking anti–IL-22 Ab. At the microscopic level, IL-22–deficient mice showed a dramatic decrease in the development of pustules and a partial decrease in acanthosis. At the molecular level, the absence or inhibition of IL-22 strongly decreased the expression of chemotactic factors such as CCL3 and CXCL3 and of biomarkers such as S100A8, S100A7, and keratin 14, which reflect the antimicrobial and hyperproliferative responses of keratinocytes. IL-22 also played a major role in neutrophil infiltration after imiquimod treatment. IL-23 was required for IL-22 production, and γδ TCR lymphocytes represented the major source of IL-22 in lymph nodes from imiquimod-treated mice. However, T cells were not absolutely required for IL-22 production because imiquimod-induced IL-22 expression in the skin is still preserved in Rag2−/− mice. Taken together, our data show that IL-22 is required for psoriasis-like lesions in the mouse imiquimod model and is produced by both T cells and innate immune cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Self-citationImiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Wolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C., & Diefenbach, A. (2009) · Nature Immunology · doi:10.1038/ni.1684 · Cited by 847
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.003 · Cited by 800
Luci, C., Reynders, A., Ivanov, I. I., Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. (2009) · Nature Immunology · doi:10.1038/ni.1681 · Cited by 554
Ma, H.-L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M., Gill, D., Dunussi-Joannopoulos, K., Collins, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33263 · Cited by 544
Self-citationWolk, K., Haugen, H. S., Xu, W., Witte, E., Waggie, K., Anderson, M., vom Baur, E., Witte, K., Warszawska, K., Philipp, S., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0457-0 · Cited by 412
Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thürlimann, W., Burg, G., Nestle, F. O., & Dummer, R. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.12.1490 · Cited by 408
Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L., Timms, K., Gutin, A., Abkevic, V., Burden, A. D., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0397-0 · Cited by 408
Immunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L., Renauld, J.-C., & Becher, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8098 · Cited by 333
Self-citationColonna, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.008 · Cited by 307
A role for T cell-derived interleukin 22 in psoriatic skin inflammation
Boniface, K., Guignouard, E., Pedretti, N., Garcia, M., Delwail, A., Bernard, F.-X., Nau, F., Guillet, G., Dagregorio, G., Yssel, H., et al. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03511.x · Cited by 290
Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
Nair, R. P., Ruether, A., Stuart, P. E., Jenisch, S., Tejasvi, T., Hiremagalore, R., Schreiber, S., Kabelitz, D., Lim, H. W., Voorhees, J. J., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701255 · Cited by 282
Geisse, J. K., Rich, P., Pandya, A., Gross, K., Andres, K., Ginkel, A., & Owens, M. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.126215 · Cited by 281
Gudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700807 · Cited by 266
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Self-citationCCR6 is required for IL-23–induced psoriasis-like inflammation in mice
Hedrick, M. N., Lonsdorf, A. S., Shirakawa, A.-K., Lee, C.-C. R., Liao, F., Singh, S. P., Zhang, H. H., Grinberg, A., Love, P. E., Hwang, S. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37378 · Cited by 238
Geboes, L., Dumoutier, L., Kelchtermans, H., Schurgers, E., Mitera, T., Renauld, J., & Matthys, P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24220 · Cited by 235
Self-citationCD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
de Jong, A., Peña-Cruz, V., Cheng, T.-Y., Clark, R. A., Van Rhijn, I., & Moody, D. B. (2010) · Nature Immunology · doi:10.1038/ni.1956 · Cited by 231
Psoriasis – as an autoimmune disease caused by molecular mimicry
Valdimarsson, H., Thorleifsdottir, R. H., Sigurdardottir, S. L., Gudjonsson, J. E., & Johnston, A. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.008 · Cited by 221
New Insights in the Immunologic Basis of Psoriasis
Nograles, K. E., Davidovici, B., & Krueger, J. G. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.03.001 · Cited by 196
Szeimies, R.-M., Gerritsen, M.-J. P., Gupta, G., Ortonne, J. P., Serresi, S., Bichel, J., Lee, J. H., Fox, T. L., & Alomar, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.022 · Cited by 193
Caproni, M., Antiga, E., Melani, L., Volpi, W., Del Bianco, E., & Fabbri, P. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9233-0 · Cited by 181
Haider, A. S., Lowes, M. A., Suárez-Fariñas, M., Zaba, L. C., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., & Krueger, J. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1913 · Cited by 173
Wolk, K., Witte, K., Witte, E., Prösch, S., Schulze-Tanzil, G. G., Nasilowska, K., John, T., Asadullah, K., Sterry, W., Volk, H., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807525 · Cited by 167
Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
Nakajima, K., Kanda, T., Takaishi, M., Shiga, T., Miyoshi, K., Nakajima, H., Kamijima, R., Tarutani, M., Benson, J. M., Elloso, M. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000148 · Cited by 160
Maele, L. V., Carnoy, C., Cayet, D., Songhet, P., Dumoutier, L., Ferrero, I., Janot, L., Erard, F., Bertout, J., Léger, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000115 · Cited by 146
Self-citationPsoriasis induced by topical imiquimod
Wu, J. K., Siller, G., & Strutton, G. M. (2004) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2004.00030.x · Cited by 146
Eyerich, S., Wagener, J., Wenzel, V., Scarponi, C., Pennino, D., Albanesi, C., Schaller, M., Behrendt, H., Ring, J., Schmidt‐Weber, C. B., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201041197 · Cited by 140
Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism
Patel, U., Mark, N. M., Machler, B. C., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10124.x · Cited by 116
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod
Fanti, P. A., Dika, E., Vaccari, S., Miscial, C., & Varotti, C. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02980.x · Cited by 96
Regulation and function of IL-17A- and IL-22-producing γδ T cells
Ness-Schwickerath, K. J., & Morita, C. T. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0700-z · Cited by 91
Animal models of psoriasis: a critical appraisal
Schön, M. P. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00751.x · Cited by 91
Smith, R. L., Warren, R. B., Eyre, S., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701140 · Cited by 87
Galbraith, G. M. P. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)79230-x · Cited by 83
Lo, Y., Torii, K., Saito, C., Furuhashi, T., Maeda, A., & Morita, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.03.018 · Cited by 82
Seung, N. R., Park, E. J., Kim, C. W., Kim, K. H., Kim, K. J., Cho, H. J., & Park, H. R. (2007) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00756.x · Cited by 76
Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis
Toichi, E., Tachibana, T., & Furukawa, F. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103264 · Cited by 56
Uyttenhove, C., Sommereyns, C., Théate, I., Michiels, T., & Snick, J. V. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.035 · Cited by 43
Dumoutier, L., de Heusch, M., Orabona, C., Satoh‐Takayama, N., Eberl, G., Sirard, J., Santo, J. P. D., & Renauld, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201040878 · Cited by 33
Self-citation
Cited by
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Mechanisms regulating skin immunity and inflammation
Pasparakis, M., Haase, I., & Nestle, F. O. (2014) · Nature Reviews Immunology · doi:10.1038/nri3646 · Cited by 886
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E., & Krueger, J. G. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.005 · Cited by 537
Metadata
- Authors
- Van Belle, A. B., de Heusch, M., Lemaire, M. M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., Fouser, L. A., Renauld, J.-C., & Dumoutier, L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 188
- Issue
- 1
- Pages
- 462-469
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2155582127
- Cited by
- 287
- References
- 53
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.